Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Verstockt

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
British Journal of Clinical Pharmacology|February 19, 2021
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseasesWannee Kantasiripitak, Bram Verstockt, Dahham Alsoud, et al.
United European Gastroenterology Journal|November 9, 2019
Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experienceBram Verstockt, Charlotte Claeys, Gert De Hertogh, et al.
Journal of Crohn'S & Colitis|November 27, 2020
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab ConcentrationsNathalie Van den Berghe, Bram Verstockt, Ann Gils, et al.
Inflammatory Bowel Diseases|October 27, 2025
Heterogeneity in Histological Evaluation of Microscopic Colitis in Randomized Clinical Trials: An Umbrella ReviewYuhong Yuan, Kato Vanden Kerchove, Christopher Ma, et al.
Cells|August 1, 2020
Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative ColitisHo-Su Lee, Maaike Vancamelbeke, Sare Verstockt, et al.
European Journal of Gastroenterology & Hepatology|March 7, 2019
Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decadesAnnick Moens, Bram Verstockt, Kathleen Machiels, et al.
Journal of Crohn'S & Colitis|January 2, 2025
Anti-TNF nonresponse in ulcerative colitis: correcting for mucosal drug exposure reveals distinct cytokine profilesJoep van Oostrom, Jurij Hanzel, Bram Verstockt, et al.
Journal of Crohn'S & Colitis|September 11, 2021
Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case SeriesFrank Phillips, Bram Verstockt, Davide Giuseppe Ribaldone, et al.
Journal of Crohn'S & Colitis|May 9, 2022
Real-world Endoscopic and Histological Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative ColitisDahham Alsoud, Gert De Hertogh, Griet Compernolle, et al.
Inflammatory Bowel Diseases|December 25, 2024
Dietary Carrageenan Amplifies the Inflammatory Profile, but not Permeability, of Intestinal Epithelial Cells from Patients With Crohn's DiseaseEva Vissers, Judith Wellens, Lorenzo Giorio, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
British Journal of Clinical Pharmacology|February 19, 2021
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseasesWannee Kantasiripitak, Bram Verstockt, Dahham Alsoud, et al.
United European Gastroenterology Journal|November 9, 2019
Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experienceBram Verstockt, Charlotte Claeys, Gert De Hertogh, et al.
Journal of Crohn'S & Colitis|November 27, 2020
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab ConcentrationsNathalie Van den Berghe, Bram Verstockt, Ann Gils, et al.
Inflammatory Bowel Diseases|October 27, 2025
Heterogeneity in Histological Evaluation of Microscopic Colitis in Randomized Clinical Trials: An Umbrella ReviewYuhong Yuan, Kato Vanden Kerchove, Christopher Ma, et al.
Cells|August 1, 2020
Molecular Changes in the Non-Inflamed Terminal Ileum of Patients with Ulcerative ColitisHo-Su Lee, Maaike Vancamelbeke, Sare Verstockt, et al.
European Journal of Gastroenterology & Hepatology|March 7, 2019
Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decadesAnnick Moens, Bram Verstockt, Kathleen Machiels, et al.
Journal of Crohn'S & Colitis|January 2, 2025
Anti-TNF nonresponse in ulcerative colitis: correcting for mucosal drug exposure reveals distinct cytokine profilesJoep van Oostrom, Jurij Hanzel, Bram Verstockt, et al.
Journal of Crohn'S & Colitis|September 11, 2021
Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case SeriesFrank Phillips, Bram Verstockt, Davide Giuseppe Ribaldone, et al.
Journal of Crohn'S & Colitis|May 9, 2022
Real-world Endoscopic and Histological Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative ColitisDahham Alsoud, Gert De Hertogh, Griet Compernolle, et al.
Inflammatory Bowel Diseases|December 25, 2024
Dietary Carrageenan Amplifies the Inflammatory Profile, but not Permeability, of Intestinal Epithelial Cells from Patients With Crohn's DiseaseEva Vissers, Judith Wellens, Lorenzo Giorio, et al.
Pageof 17